(Q52241406)

27 April 2018

review article

1 reference

title

Optimizing therapy for complex or refractory heart failure: a management algorithm. (English)

1 reference

27 April 2018

1 reference

Stevenson LW

1

1 reference

27 April 2018

Massie BM

series ordinal

2

1 reference

27 April 2018

Francis GS

series ordinal

3

1 reference

27 April 2018

language of work or name

English

0 references

publication date

1 June 1998

1 reference

27 April 2018

published in

American Heart Journal

1 reference

27 April 2018

volume

135

1 reference

27 April 2018

issue

6 Pt 2 Su

1 reference

27 April 2018

page(s)

S293-309

1 reference

27 April 2018

Changing epidemiological features of cardiac failure

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970257-1

Heart failure: a growing public health problem

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970257-1

Management of heart failure. III. The role of revascularization in the treatment of patients with moderate or severe left ventricular systolic dysfunction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970257-1

Predictability of mitral regurgitation detected by Doppler echocardiography in patients referred for cardiac transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970257-1

Does the magnitude of mitral regurgitation determine hemodynamic response to vasodilation in chronic congestive heart failure?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970257-1

Afterload reduction with vasodilators and diuretics decreases mitral regurgitation during upright exercise in advanced heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970257-1

Beneficial effects of vasodilator agents in severe mitral regurgitation due to dysfunction of subvalvar apparatus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970257-1

Low-dose amiodarone for atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970257-1

Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970257-1

Heart failure associated with preserved systolic function: a common and costly clinical entity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970257-1

Management of heart failure. II. Counseling, education, and lifestyle modifications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970257-1

Management of heart failure. I. Pharmacologic treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970257-1

Discontinuation of chronic diuretic therapy in stable congestive heart failure secondary to coronary artery disease or to idiopathic dilated cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970257-1

Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970257-1

The effect of digoxin on mortality and morbidity in patients with heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970257-1

Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. RADIANCE Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970257-1

Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial. PROVED Investigative Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970257-1

Bedside cardiovascular examination in patients with severe chronic heart failure: importance of rest or inducible jugular venous distension.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970257-1

Left ventricular dysfunction--bedside Valsalva manoeuvre

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970257-1

Maintenance of cardiac output with normal filling pressures in patients with dilated heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970257-1

Metolazone in treatment of severe refractory congestive cardiac failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970257-1

Sustained hemodynamic efficacy of therapy tailored to reduce filling pressures in survivors with advanced heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970257-1

Intermittent administration of furosemide vs continuous infusion preceded by a loading dose for congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970257-1

Sustained cardiac diastolic changes elicited by ultrafiltration in patients with moderate congestive heart failure: pathophysiological correlates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970257-1

The association between the quality of inpatient care and early readmission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970257-1

Treatment of refractory heart failure with infusion of nitroprusside.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970257-1

The cardiovascular effects of the continuous infusion of dobutamine in patients with severe cardiac failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970257-1

Impact of a comprehensive heart failure management program on hospital readmission and functional status of patients with advanced heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970257-1

Long-term vasodilator therapy for heart failure: clinical response and its relationship to hemodynamic measurements.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970257-1

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970257-1

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970257-1

Comparison of captopril and enalapril in patients with severe chronic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970257-1

Hemodynamic effects of orally administered isosorbide dinitrate in patients with congestive heart failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970257-1

Persistent hemodynamic improvement with short-term nitrate therapy in patients with chronic congestive heart failure already treated with captopril

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970257-1

Effect of direct vasodilation with hydralazine versus angiotensin-converting enzyme inhibition with captopril on mortality in advanced heart failure: the Hy-C trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970257-1

Improved exercise capacity and differing arterial and venous tolerance during chronic isosorbide dinitrate therapy for congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970257-1

Nitrates in the treatment of congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970257-1

Effect of intervals between doses on the development of tolerance to isosorbide dinitrate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970257-1

Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970257-1

Hemodynamic responses to combined therapy with captopril and hydralazine in patients with severe heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970257-1

Beneficial effects of hydralazine on rest and exercise hemodynamics in patients with chronic severe aortic insufficiency.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970257-1

Minoxidil therapy in chronic congestive heart failure: acute plus long-term hemodynamic and clinical study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970257-1

Diltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction. The Adverse Experience Committee; and the Multicenter Diltiazem Postinfarction Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970257-1

A prospective, randomized, double-blind, crossover study to compare the efficacy and safety of chronic nifedipine therapy with that of isosorbide dinitrate and their combination in the treatment of chronic congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970257-1

Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970257-1

Placebo controlled trial of felodipine in patients with mild to moderate heart failure. UK Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970257-1

Improvement in exercise capacity of candidates awaiting heart transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970257-1

Intermittent inotropic therapy in an outpatient setting: a cost-effective therapeutic modality in patients with refractory heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970257-1

Circulatory status and response to cardiac rehabilitation in patients with heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970257-1

Double-blind, placebo-controlled study of the long-term efficacy of carvedilol in patients with severe chronic heart failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970257-1

Randomised trial of low-dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970257-1

Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970257-1

A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970257-1

Improving survival for patients with advanced heart failure: A study of 737 consecutive patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970257-1

The heart failure epidemic: magnitude of the problem and potential mitigating approaches.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970257-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-8703(98)70257-1

1 reference

27 April 2018

1 reference

27 April 2018